IBEX TECHNOLOGIES INC (IBT.CA) Stock Price, Forecast & Analysis
TSX-V:IBT • CA4489375085
IBT.CA Key Statistics, Chart & Performance
The current stock price of IBT.CA is 1.44 CAD. In the past month the price increased by 2.86%. In the past year, price increased by 89.47%.
IBT.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to IBT.CA. When comparing the yearly performance of all stocks, IBT.CA is one of the better performing stocks in the market, outperforming 94.53% of all stocks.
IBT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to IBT.CA. IBT.CA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
IBT.CA Financial Highlights
Over the last trailing twelve months IBT.CA reported a non-GAAP Earnings per Share(EPS) of 0.16. The EPS increased by 139.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 51.82% | ||
| ROA | 22.64% | ||
| ROE | 28.25% | ||
| Debt/Equity | 0.1 |
IBT.CA Forecast & Estimates
IBT.CA Ownership
IBT.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 583.286M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 397.882M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 150.469M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 79.24M | ||
| COV | COVALON TECHNOLOGIES LTD | 13.18 | 52.478M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 39.44M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 5.94 | 33.252M | ||
| RVX | RESVERLOGIX CORP | N/A | 33.069M | ||
| HEM | HEMOSTEMIX INC | N/A | 17.573M | ||
| MPH | MEDICURE INC | N/A | 11.693M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About IBT.CA
Company Profile
IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The firm also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The firm has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The firm operates in one industry segment: the production and sale of diagnostic products.
Company Info
IBEX TECHNOLOGIES INC
Suite 100, 5485 Pare Street
MONTREAL QUEBEC H4P 1P7 CA
CEO: Paul Baehr
Employees: 0
Phone: 15143444004
IBEX TECHNOLOGIES INC / IBT.CA FAQ
Can you describe the business of IBEX TECHNOLOGIES INC?
IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The firm also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The firm has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The firm operates in one industry segment: the production and sale of diagnostic products.
What is the stock price of IBEX TECHNOLOGIES INC today?
The current stock price of IBT.CA is 1.44 CAD.
Does IBT stock pay dividends?
IBT.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of IBT stock?
IBT.CA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for IBEX TECHNOLOGIES INC?
IBEX TECHNOLOGIES INC (IBT.CA) operates in the Health Care sector and the Biotechnology industry.
Should I buy IBT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IBT.CA.